Stockreport

Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell

Salarius Pharmaceuticals, Inc.  (SLRX) 
PDF HOUSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, [Read more]